Mon, Apr 21, 2014, 5:25 AM EDT - U.S. Markets open in 4 hrs 5 mins

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • daolag daolag Apr 19, 2013 4:53 PM Flag

    Special Note: Safety not ready yet

    Special Note Regarding Forward-Looking Statements
    This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, Dr. Mueller's statements in the second paragraph of this press release and statements regarding (i) Vertex’s plans to conduct additional studies of VX-661 to further evaluate its potential for late-stage development; (ii) Vertex’s expectation that it will obtain 24-week safety and efficacy data from its Phase 3 studies of VX-809 in combination with ivacaftor and submit an NDA to the FDA in 2014, (iii) Vertex’s plans to begin a 28-day study of VX-983 in combination with ivacator in the second half of 2013

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
VRTX
64.17-0.22(-0.34%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AstraZeneca PLC
NYSEThu, Apr 17, 2014 4:00 PM EDT
Snap-on Inc.
NYSEThu, Apr 17, 2014 4:01 PM EDT